Author of the publication

Examining the In Vitro Efficacy of the IAP Antagonist Birinapant as a Single Agent or in Combination With Dacarbazine to Induce Melanoma Cell Death

, , , , , and . Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, 25 (9): 1489--1494 (November 2017)
DOI: 10.3727/096504017x14897145996933

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Melanoma 2.0. Skin cancer as a paradigm for emerging diagnostic technologies, computational modelling and artificial intelligence, , , , , , , , , and 8 other author(s). Briefings in Bioinformatics, (October 2022)Apoptotic cell death in disease---Current understanding of the NCCD 2023, , , , , , , , , and 218 other author(s). Cell Death & Differentiation, 30 (5): 1097--1154 (May 1, 2023)A Machine Learning Platform to Optimize the Translation of Personalized Network Models to the Clinic., , , , , , , , , and 7 other author(s). JCO clinical cancer informatics, (April 2019)cFLIP downregulation is an early event required for endoplasmic reticulum stress-induced apoptosis in tumor cells, , , and . Cell Death & Disease, 13 (2): 111 (Feb 3, 2022)Applying GAN-based data augmentation to improve transcriptome-based prognostication in breast cancer, , and . (October 2022)Transcriptional CDK Inhibitors CYC065 and THZ1 Induce Apoptosis in Glioma Stem Cells Derived from Recurrent GBM, , , , , and . Cells, 10 (5): 1182 (2021)ER stress-induced cell death proceeds independently of the TRAIL-R2 signaling axis in pancreatic β cells, , , , , and . Cell Death Discovery, 8 (1): 34 (Jan 24, 2022)Whither systems medicine?, , , , , , , , , and 22 other author(s). Experimental And Molecular Medicine, (2018)Cyclin dependent kinase inhibition : a novel treatment strategy for glioblastoma, , , , , , , , , and 4 other author(s). 30th EORTC - NCI - AACR Symposium, 103, 1, page E42-E43. Amsterdam, Elsevier, (2018)Development of a protein signature to enable clinical positioning of IAP inhibitors in colorectal cancer, , , , , , , , , and . The FEBS journal, 288 (18): 5374-5388 (2021)